Bharat Parenterals Ltd - 541096 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Bharat Parenterals Ltd - 541096 - Grant Of Employee Stock Options Under BPL ESOP-2020
Grant of Employee Stock options under BPL ESOP-2020 Bharat Parenterals Ltd - 541096 - Results For The Quarter And Half Year Ended September 30, 2020
Financial Results For The Quarter And Half Year Ended September 30, 2020 Bharat Parenterals Ltd - 541096 - Financial Results For The Quarter And Half Year Ended September 30, 2020
Financial Results For The Quarter and Half Year Ended September 30, 2020 Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2020
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve 1. The unaudited financial results of the Company for the Quarter and Half Year ended on September 30, 2020. 2. To approve the grant of stock options under 'Bharat Parenterals Employee Stock Option Plan 2020' ('BPL ESOP 2020'). Bharat Parenterals Ltd - 541096 - Shareholding for the Period Ended September 30, 2020
Bharat Parenterals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Bharat Parenterals Ltd - 541096 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation,2018 For Half Year Ended On September 30,2020
Certificate under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation,2018 for half year ended on September 30,2020 Bharat Parenterals Ltd - 541096 - Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2020
Pursuant to Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are submitting herewith a Certificate, duly signed by Adroit Corporate Services Pvt. Ltd., Registrar & Share Transfer Agent of the Company and Compliance Officer of Bharat Parenterals Limited, for the half year ending on 30.09.2020 for your information and records. Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for quarter ended on September 30,2020. Bharat Parenterals Ltd - 541096 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- LUBHANSHI JHALANIDesignation :- Company Secretary and Compliance Officer